Envista Holdings (Envista Holdings) Research & Development

: $94 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

Research & Development is the aggregate amount of research and development expenses during the year. Envista Holdings's Research & Development for the three months ended in Dec. 2023 was $20 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $94 Mil.

Envista Holdings Research & Development Historical Data

The historical data trend for Envista Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envista Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

133.10

86.70

100.50

100.10

93.80

Envista Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development																24.60	24.50	26.80	22.30	20.20

Envista Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $94 Mil.

Envista Holdings (NYSE:NVST) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Envista Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Envista Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Envista Holdings (Envista Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envista Holdings Corp (NYSE:NVST) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

0HV:Germany 0HV:Germany

Address

200 S. Kraemer Boulevard, Building E, Brea, CA, USA, 92821

Website

https://www.envistaco.com

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

Executives

Eric Conley	officer: SVP, Orthodontics	200 S. KRAEMER BLVD, BLDG E, BREA CA 92821
Mark E Nance	officer: Senior Vice President, GC, Sec	1333 S SPECTRUM BLVD #100, CHANDLER AZ 85286
Stephen Keller	officer: Principal Financial Officer	200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Amir Aghdaei	director, officer: PRESIDENT AND CEO	C/O CREDENCE SYSTEMS CORPORATION, 1421 CALIFORNIA CIRCLE, MILPITAS CA 95035
Faez C Kaabi	officer: Chief Accounting Officer	200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Howard H Yu	officer: SENIOR VICE PRESIDENT, CFO	250 S. KRAEMER BLVD., BREA CA 92821
Mischa Reis	officer: SENIOR VICE PRESIDENT	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Curt W Bludworth	officer: SENIOR VICE PRESIDENT, CHRO	250 S. KRAEMER BLVD., BREA CA 92821
Barbara B. Hulit	director	C/O FORTIVE CORPORATION, 6920 SEAWAY BLVD, EVERETT WA 98203
Jeffrey Kappler	officer: SENIOR VICE PRESIDENT	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Teresa Gayle Sheppard	director	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Vivek Jain	director	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Jean-claude Kyrillos	officer: Senior Vice President	C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Kieran Gallahue	director	PO BOX 684369, PARK CITY UT 84068
William K Daniel	director	2135 WEST MAPLE ROAD, TROY MI 48084